COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,831 Articles (22,553 medRxiv, 8,278 bioRxiv)

Most recent first Previous |  Page 563: Articles 5621-5630  | Next

Utility of human judgment ensembles during times of pandemic uncertainty: A case study during the COVID-19 Omicron BA.1 wave in the USA
Venkatramanan, S., Cambeiro, J., Liptay, T., Lewis, B., Orr, M., Dempsey, G., Telionis, A., Crow, J., Barrett, C., Marathe, M.
10.1101/2022.10.12.22280997 — Posted: 2022-10-13
Evaluating an epidemiologically motivated surrogate model of a multi-model ensemble
Abbott, S., Sherratt, K., Bosse, N., Gruson, H., Bracher, J., Funk, S.
10.1101/2022.10.12.22280917 — Posted: 2022-10-13
Age-stratified infection fatality rate of COVID-19 in the non-elderly informed from pre-vaccination national seroprevalence studies
Pezzullo, A. M., Axfors, C., Contopoulos-Ioannidis, D. G., Apostolatos, A., Ioannidis, J. P. A.
10.1101/2022.10.11.22280963 — Posted: 2022-10-13
Anti-SARS-CoV-2 antibody containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 via increased neutralizing antibody activity. A randomized clinical trial
Denkinger, C. M., Janssen, M., Schaekel, U., Gall, J., Leo, A., Stelmach, P., Weber, S. F., Krisam, J., Baumann, L., Stermann, J., Merle, U., Weigand, M. A., Nusshag, C., Bullinger, L., Schrezenmeier, J.-F., Bornhaeuser, M., Alakel, N., Witzke, O., Wolf, T., Vehreschild, M. J., Schmiedel, S., Addo, M. M., Herth, F., Kreuter, M., Tepasse, P.-R., Hertenstein, B., Haenel, M., Morgner, A., Kiehl, M., Hopfer, O., Wattad, M.-A., Schimanski, C. C., Celik, C., Pohle, T., Ruhe, M., Kern, W. V., Schmitt, A., Lorenz, H.-M., Souto-Carneiro, M., Gaeddert, M., Halama, N., Meuer, S., Kraeusslich, H.-G., Mueller, B., Schnitzler, P., Parthe, S., Bartenschlager, R., Gronkowski, M., Klemmer, J., Schmitt, M., Dreger, P., Kriegsmann, K., Schlenk, R. F., Mueller-Tidow, C.
10.1101/2022.10.10.22280850 — Posted: 2022-10-13
High titers of infectious SARS-CoV-2 in COVID-19 corpses
Saitoh, H., Sakai, Y. T., Nagasawa, S., Torimitsu, S., Kubota, K., Hirata, Y., Iwatsuki, K. H., Motomura, A., Ishii, N., Okaba, K., Horioka, K., Abe, H., Ikemura, M., Rokutan, H., Hinata, M., Iwasaki, A., Yasunaga, Y., Nakajima, M., Yamaguchi, R., Tsuneya, S., Kira, K., Kobayashi, S., Inokuchi, G., Chiba, F., Hoshioka, Y., Mori, A., Yamamoto, I., Nakagawa, K., Katano, H., Iida, S., Suzuki, T., Akitomi, S., Hasegawa, I., Ushiku, T., Yajima, D., Iwase, H., Makino, Y., Kawaoka, Y.
10.1101/2022.10.11.22280868 — Posted: 2022-10-13
Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study
Otiende, M. O., Nyaguara, A., Bottomley, C., Walumbe, D., Mochamah, G., Amadi, D., Nyundo, C., Kagucia, E., Etyang', A., Adetifa, I., Brand, S. P., Maitha, E., Chondo, E., Nzomo, E., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., Ng'ang'a, W., Barasa, E., Tsofa, B., Mwangangi, J., Bejon, P., Agweyu, A., Williams, T., Scott, A.
10.1101/2022.10.12.22281019 — Posted: 2022-10-13
Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening
Kucharski, A., Chung, K., Aubry, M., Teiti, I., Teissier, A., Richard, V., Russell, T., Bos, R., Olivier, S., Cao-Lormeau, V.-M.
10.1101/2022.10.12.22280928 — Posted: 2022-10-13
Quantifying changes in the IFR and IHR over 23 months of the SARS-CoV-2 pandemic in England
Eales, O., Haw, D., Wang, H., Atchison, C., Ashby, D., Cooke, G., Barclay, W., Ward, H., Darzi, A., Donnelly, C. A., Chadeau-Hyam, M., Elliott, P., Riley, S.
10.1101/2022.10.12.22281016 — Posted: 2022-10-13
Cytosolic Proliferating Cell Nuclear Antigen (PCNA) interacts with S100A8 and controls an inflammatory subset of neutrophils in COVID-19
Formiga, R., Pesenti, L., Ladjemi, M. Z., Andrieu, M., Many, S., Karunanithy, V., Bailly, K., Dhote, T., Starick, M., Lummertz da Rocha, E., Puig Lombardi, E., Frachet, P., Granger, V., de Chaisemartin, L., Chollet-Martin, S., Mouthon, L., Spiller, F., Hosmalin, A., Hurtado-Nedelec, M., Martin, C., Pene, F., Burgel, P.-R., Tourneur, L., Witko-Sarsat, V.
10.1101/2022.10.12.22280984 — Posted: 2022-10-13
Analysis of fatality among COVID-19 cases in Mexican pregnant women: a cross-sectional study
Padilla-Raygoza, N., Gallardo-Luna, M. d. J., Flores-Vargas, G., Navarro-Olivos, E., Magos-Vazquez, F. J., Lara-Lona, E., Diaz-Martinez, D. A.
10.1101/2022.10.12.22280996 — Posted: 2022-10-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).